In a continuing crackdown on the sale of bootleg GLP-1 weight loss drugs, AG Tong this month sent cease and desist letters to weight loss spas in Avon, Brookfield and Danbury advertising non-FDA approved compounded GLP-1 weight loss drugs despite a state warning that such practices could violate the Connecticut Unfair Trade Practices Act.

Companies receiving the letters include CT Weight Loss Shot, which operates CT Weight Loss Shot in Danbury and Vigorous 360 Wellness in Brookfield and Radiance Medspa in Avon. The businesses each advertise and prescribe compounded semaglutide and/or tirzepatide GLP-1 weight loss injections. The letters demand that the businesses immediately cease false and misleading marketing of these products, and further demand that any owners who are not licensed healthcare providers divest their interests in the businesses.

“There are currently no generic GLP-1 weight loss injections on the market, and anyone advertising or offering this is not telling the truth and exposing patients to potentially unsafe bootleg drugs. Our ongoing investigation into these knockoffs found three clinics, owned or controlled by laypeople, not licensed healthcare providers, deceptively marketing these compounded injections in Connecticut. We have sent cease-and-desist letters to each of these clinics, and will not hesitate to take further action to protect patients and consumers.

 - AG Tong